XIGDUO XR 1000 mg/1

Xigduo XR combines dapagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes.

Xigduo XR is primarily used to improve glycemic control in adults with type 2 diabetes. The combination of dapagliflozin and metformin hydrochloride works to lower blood sugar levels. This medication is often prescribed as part of a broader diabetes management plan, which may include diet and exercise.

Common effects of Xigduo XR may include gastrointestinal discomfort, such as nausea or diarrhea. Some users may experience urinary tract infections or symptoms related to low blood sugar. Extended-release tablets are designed to minimize these effects by releasing the medication gradually.

Xigduo XR should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow medical guidance regarding its use. Always store the medication as directed and keep it out of reach of children.

Xigduo XR may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol and some over-the-counter drugs can also influence its effectiveness. Always consult a healthcare provider before combining Xigduo XR with other treatments.